Drug Profile
Monoclonal antibody TES 23
Alternative Names: Monoclonal antibody TES-23; TES-23Latest Information Update: 15 Mar 2007
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical; Osaka University
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 15 Mar 2007 Discontinued - Preclinical for Solid tumours in Japan (unspecified route)
- 25 May 1999 Preclinical development for Solid tumours in Japan (Unknown route)